Tower Research Capital LLC (TRC) - NEXIMMUNE INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of NEXIMMUNE INC
ValueSharesWeighting
Q3 2023$1,342
-25.6%
6,390
-0.0%
0.00%
Q2 2023$1,803
+90050.0%
6,392
-1.9%
0.00%
Q1 2023$20.0%6,515
-0.3%
0.00%
Q4 2022$2
-100.0%
6,534
-53.1%
0.00%
Q3 2022$8,000
+14.3%
13,921
+219.8%
0.00%
Q2 2022$7,000
-73.1%
4,353
-28.9%
0.00%
Q1 2022$26,000
+100.0%
6,122
+116.5%
0.00%
Q4 2021$13,000
+62.5%
2,828
+443.8%
0.00%
Q3 2021$8,000
-63.6%
520
-62.2%
0.00%
-100.0%
Q2 2021$22,000
+340.0%
1,377
+473.8%
0.00%
Q1 2021$5,0002400.00%
Other shareholders
NEXIMMUNE INC shareholders Q4 2023
NameSharesValueWeighting ↓
EPIQ Capital Group, LLC 390,600$110,0710.06%
M28 Capital Management LP 133,442$37,6040.05%
ALLEN OPERATIONS LLC 635,934$179,3330.04%
Slate Path Capital LP 925,000$260,6650.01%
Caprock Group, LLC 103,482$29,1610.00%
OSAIC HOLDINGS, INC. 600$1690.00%
ADAGE CAPITAL PARTNERS GP, L.L.C. 801,371$225,8260.00%
TWO SIGMA INVESTMENTS, LP 22,577$6,3620.00%
GEODE CAPITAL MANAGEMENT, LLC 61,732$17,2170.00%
MILLENNIUM MANAGEMENT LLC 59,593$16,6200.00%
View complete list of NEXIMMUNE INC shareholders